Inventor · disambiguated record
Timothy Vickers
Also filed as: VICKERS TIMOTHY · VICKERS TIMOTHY A
20 granted patents·16 pending applications·824 citations·filing 1991–2014
96Inventor score
Top patents by PatentIndex Score
36 records- 0198US7235653B2Oligonucleotide compositions and methods for the modulation of the expression of B7 proteinISIS PHARMACEUTICALS INC·Filed 2003·Granted Jun 26, 2007·117 cites·11 claims
- 0296US7879992B2Modification of MyD88 splicing using modified oligonucleotidesISIS PHARMACEUTICALS INC·Filed 2006·Granted Feb 1, 2011·42 cites·27 claims
- 0395US7321828B2System of components for preparing oligonucleotidesISIS PHARMACEUTICALS INC·Filed 1998·Granted Jan 22, 2008·216 cites·4 claims
- 0492US5952490AOligonucleotides having a conserved G4 core sequenceISIS PHARMACEUTICALS INC·Filed 1993·Granted Sep 14, 1999·69 cites·27 claims
- 0589US6034233A2'-O-alkylated oligoribonucleotides and phosphorothioate analogs complementary to portions of the HIV genomeISIS PHARMACEUTICALS INC·Filed 1991·Granted Mar 7, 2000·125 cites·7 claims
- 0683US6077833AOligonucleotide compositions and methods for the modulation of the expression of B7 proteinISIS PHARMACEUTICALS INC·Filed 1996·Granted Jun 20, 2000·54 cites·46 claims
- 0781US9856473B2Compositions and methods for modulation of LMNA expressionIONIS PHARMACEUTICLS INC·Filed 2014·Granted Jan 2, 2018·3 cites·14 claims
- 0881US6319906B1Oligonucleotide compositions and methods for the modulation of the expression of B7 proteinISIS PHARMACEUTICALS INC·Filed 1999·Granted Nov 20, 2001·48 cites·62 claims
- 0977US7115580B1Antisense modulation of B7 protein expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Oct 3, 2006·4 cites·40 claims
- 1073US8765703B2Modification of MYD88 splicing using modified oligonucleotidesVICKERS TIMOTHY·Filed 2010·Granted Jul 1, 2014·3 cites·20 claims
- 1172US5698391AMethods for synthetic unrandomization of oligomer fragmentsISIS PHARMACEUTICALS INC·Filed 1994·Granted Dec 16, 1997·36 cites·80 claims
- 1270US2004197814A1System of components for preparing oligonucleotidesFiled 2004·Application pending·0 cites
- 1369US5639595AIdentification of novel drugs and reagentsISIS PHAMACEUTICALS INC·Filed 1993·Granted Jun 17, 1997·42 cites·22 claims
- 1468US9550990B2Regulation of epigenetic control of gene expressionGRIFFEY RICHARD H·Filed 2005·Granted Jan 24, 2017·1 cites·4 claims
- 1568US2005033524A1Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulationFiled 2003·Application pending·0 cites
- 1667US5736294AReagents and methods for modulating gene expression through RNA mimicryISIS PHARMACEUTICALS INC·Filed 1991·Granted Apr 7, 1998·22 cites·14 claims
- 1765US5874564AReagents and methods for modulating gene expression through RNA mimicryISIS PHARMACEUTICALS INC·Filed 1995·Granted Feb 23, 1999·25 cites·15 claims
- 1864US2006069518A1Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulationISIS PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 1963US2003113739A1System of components for preparing oligonucleotidesFiled 2002·Application pending·0 cites
- 2061US8093061B2Methods of determining potency of chemically-synthesized oligonucleotidesLIMA WALTER F·Filed 2007·Granted Jan 10, 2012·0 cites·39 claims
- 2161US2007270363A1Modulation of telomere length by oligonucleotides having a G-core sequenceBENNETT C F·Filed 2006·Application pending·0 cites
- 2259US2013252243A1Methods of determining potency of chemically-synthesized oligonucleotidesISIS PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 2359US2007015723A1Antiviral oligonucleotides having a conserved G4 core sequenceISIS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2458US2004137471A1Efficient reduction of target RNA's by single-and double-stranded oligomeric compoundsFiled 2003·Application pending·0 cites
- 2557US2003228597A1Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulationFiled 2003·Application pending·0 cites
- 2656US8338185B2Methods of determining potency of chemically-synthesized oligonucleotidesLIMA WALTER F·Filed 2011·Granted Dec 25, 2012·0 cites·13 claims
- 2756US2010041047A1Efficient reduction of target rna's by single- and double-stranded oligomeric compoundsVICKERS TIMOTHY·Filed 2009·Application pending·0 cites
- 2855US2005261228A1Antisense modulation of interleukin 12 P35 subunit expressionBENNETT C F·Filed 2005·Application pending·0 cites
- 2953US2011124715A1Antiviral Oligonucleotides Having a Conserved G4 Core SequenceHANECAK RONNIE C·Filed 2010·Application pending·0 cites
- 3050US2004023917A1Oligonucleotide compositions and methods for the modulation of the expression of B7 proteinFiled 2003·Application pending·0 cites
- 3149US2005048495A1Isoform-specific targeting of splice variantsFiled 2003·Application pending·0 cites
- 3249US2004002153A1Modulation of PTEN expression via oligomeric compoundsFiled 2003·Application pending·0 cites
- 3346US5672472ASynthetic unrandomization of oligomer fragmentsISIS PHARMACEUTICALS INC·Filed 1992·Granted Sep 30, 1997·12 cites·64 claims
- 3444US2003176374A1Oligonucleotide compositions and methods for the modulation of the expression of B7 proteinFiled 2001·Application pending·0 cites
- 3542US5866698AModulation of gene expression through interference with RNA secondary structureISIS PHARMACEUTICALS INC·Filed 1994·Granted Feb 2, 1999·5 cites·7 claims
- 3633US6368863B1Reagents and methods for modulating gene expression through RNA mimicryISIS PHARMACEUTICALS INC·Filed 1999·Granted Apr 9, 2002·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Timothy Vickers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →